InsideArbitrage Event Driven Monitor – May 8, 2026

Note: You can click on any section title to jump straight to the related tool or page.

Merger Arbitrage

1. CCRN: The acquisition of Cross Country Healthcare, Inc. (CCRN) by Knox Lane for a closing value of $437 million. Knox Lane will acquire all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash transaction, representing a premium of 31.06% from the stock’s last close. (Press Release)
2. CPRX: The acquisition of Catalyst Pharmaceuticals, Inc. (CPRX) by Angelini Pharma S.p.A. for a closing value of $4.1 billion. Angelini Pharma has agreed to acquire all outstanding shares of Catalyst for $31.5 per share in cash, representing a premium of 3.21% from the stock’s last close. Last week, Bloomberg reported that Italian drugmaker Angelini Pharma was exploring a potential acquisition of Catalyst Pharmaceuticals. (Press Release)
3. MPX: Marine Products (MPX) announced that the waiting period applicable to the merger under the HSR Act expired on April 6, 2026. The transaction is expected to close in the second quarter of 2026.

Only plus or premium subscribers can access this post. Subscribe today.